Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | APP | P05067 | 2/20 | 0.54 |
| ▸ | RELA | Q04206 | 3/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CHAT | P28329 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699705 | 1.00 | MAOB (0.56) | MAOBNFE2L2CYP19A1MAOAAPP | |
| SCHEMBL10120088 | 0.90 | MAOB (0.70) | MAOBNFE2L2CYP19A1MAOAAPP | |
| SCHEMBL699783 | 0.88 | APP (0.64) | MAOBNFE2L2CYP19A1MAOAAPP | |
| SCHEMBL699782 | 0.88 | APP (0.64) | MAOBNFE2L2CYP19A1MAOAAPP | |
| SCHEMBL83955 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA | |
| SCHEMBL44504 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA | |
| SCHEMBL14166008 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA | |
| SCHEMBL11547655 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA | |
| SCHEMBL22164138 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA | |
| SCHEMBL11547654 | 0.85 | NFE2L2 (0.72) | MAOBNFE2L2CYP19A1MAOARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404221-B2 | Methods of arene alkenylation | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-02 | — | — | US | disclosed |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-02 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-07-27 | — | — | US | disclosed |
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| CN-102005220-B | Compositions, optical data storage media and methods for using the optical data storage media | GEN ELECTRIC | 2015-06-03 | — | — | CN | disclosed |
| US-8703388-B2 | Optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2014-04-22 | — | — | US | disclosed |
| US-8507153-B2 | Compositions, optical data storage media and methods for using the optical data storage media | GENERAL ELECTRIC COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2423917-B1 | Use of chemically bonded dyes in holographic data storage media | GEN ELECTRIC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20110053054-A1 | COMPOSITIONS, OPTICAL DATA STORAGE MEDIA AND METHODS FOR USING THE OPTICAL DATA STORAGE MEDIA | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2290408-A1 | Compositions, optical data storage media and methods for using the optical data storage media | General Electric Company (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2290651-A1 | Compositions, optical data storage media and methods for using the optical data storage media | General Electric Company (US) | 2011-03-02 | — | — | EP | disclosed |
| US-20100302927-A1 | OPTICAL DATA STORAGE MEDIUM AND METHODS FOR USING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20040005649-A1 | Anti-stilbene antibodies | SCRIPPS RESEARCH INSTITUTE, THE | 2004-01-08 | — | — | US | disclosed |
| WO-2002022629-A1 | ANTI-STILBENE ANTIBODIES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | MAOB 739/4885NFE2L2 253/4885CYP19A1 1811/4885 |
| US-20230234900-A1 | METHODS OF ARENE ALKENYLATION | CYBB, CBR3, AHR | MAOB 157/4885NFE2L2 102/4885CYP19A1 504/4885 |
| US-12404221-B2 | Methods of arene alkenylation | CYBB, CBR3, AHR | MAOB 157/4885NFE2L2 102/4885CYP19A1 504/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | MAOB 739/4885NFE2L2 253/4885CYP19A1 1811/4885 |
| US-20230348524-A1 | TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION | POLRMT, DCLRE1B, RNGTT | MAOB 3769/4885NFE2L2 4162/4885CYP19A1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.